Zarminali Health Funding, Investors & Competitors

Zarminali Health has raised $150M across 2 funding rounds, most recently a $110M Series A in January 2026.

Last Zarminali Health funding round

$110M

Series A · Jan 2026

Cumulative funding Zarminali Health raised

$150M

across 2 funding rounds

Key investors in Zarminali Health

  • General Catalyst
  • Healthier Capital
  • K2 HealthVentures
  • Boston Children's Hospital

Zarminali Health Overview

About Zarminali Health

Zarminali Health is a multispecialty pediatric group practice delivering coordinated care across primary care, behavioral health, and specialties like cardiology and neurology. Headquartered in New Jersey, it integrates electronic health records and telehealth for seamless patient experiences via zarminali.com. The group serves families in the New York metropolitan area with locations in multiple states, emphasizing preventive care and family-centered treatment protocols.


Founded

2024

HQ

United StatesChicago, IL

Status

Privately held

Customer focus

B2C

Revenue model

Services

Zarminali Health Funding History

Zarminali Health has raised a total of $150M across 2 funding rounds.

Zarminali Health's first fundraising round was a $40M seed round in November 2024. The most recent completed round was a $110M Series A in January 2026.

Zarminali Health funding rounds

Zarminali Health funding rounds
DateStageInvestorsRaisedDeal Summary
Jan 2026Series AHealthier Capital (lead); General Catalyst; K2 HealthVentures; Boston Children's Hospital$110MZarminali Pediatrics, founded in 2024, is the first outpatient pediatric destination purpose-built for integrated primary and specialty care nationwide, operating 28 clinics across eight states. The company raised $110 million in a Series A funding round on January 21, 2026, led by Healthier Capital with participation from General Catalyst and new investor K2 HealthVentures, bringing total funding to $150 million. The capital will accelerate rollout of its proprietary technology platform, enable entry into new markets like Chicago, Milwaukee, and Dallas, support opening 15 de novo clinics in 2026, and expand services to include urgent care, speech therapy, occupational therapy, behavioral health, and 24/7 telehealth. Zarminali aims to transform the broken U.S. pediatric healthcare system by unifying primary, specialty, and urgent care under one family-centered, technology-enhanced model. Amir Dan Rubin, CEO and Founding Managing Partner of Healthier Capital and former CEO of Amazon One Medical, joined the board alongside members from General Catalyst, CareBridge Health, and Devoted Health. The company positions itself as the only national pediatric network integrating these services with a unified technology platform on a national scale. Plans include welcoming additional established practice groups into its network and focusing on clinician empowerment and family experience through purpose-built clinics. Investors highlight Zarminali's rapid growth, outperformance, and potential to build the first scaled, sustainable pediatric health system.
Nov 2024SeedGeneral Catalyst (lead)$40MZarminali Health (also referred to as Zarminali Pediatrics) is a Chicago-based pediatric healthcare startup founded in July 2024 by Danish Qureshi, former executive at LifeStance Health. The company provides integrated outpatient primary and specialty pediatric care through a hybrid model featuring in-person clinics for primary, urgent, and specialty services, alongside telehealth and asynchronous messaging. It launched its first operational clinic in Michigan in November 2024 and plans a fee-for-service model initially, transitioning to value-based care after proving scalability and quality outcomes. On November 20, 2024, Zarminali secured a $40 million seed funding round led by General Catalyst, including a venture debt facility. The capital supports go-to-market expansion, opening initial physical locations starting fall 2024, national footprint growth via selective acquisitions, and presence in at least 30 states within 24-36 months. General Catalyst's Holly Maloney highlighted the company's strong founding team, collaborative care model, and technology to address overlooked pediatric needs amid clinician burnout and limited hospital services. The funding validates Zarminali's mission to streamline family care journeys, improve child health outcomes, and reduce clinician burdens in a fragmented U.S. pediatric system where only 37% of hospitals offer pediatric services and over half of pediatricians report burnout. With a one-to-two year runway, the startup aims to serve over 15 million children needing specialty care. In a later development, Zarminali raised a $110 million Series A on January 21, 2026, led by Healthier Capital with General Catalyst participation, bringing total funding to $150 million for further clinic rollout, market entry, and technology platform expansion.

Who has invested in Zarminali Health?

4 investors have backed Zarminali Health across its funding rounds, including General Catalyst, Healthier Capital, K2 HealthVentures and Boston Children's Hospital.

Lead investors include Healthier Capital and General Catalyst.


Zarminali Health Investors

Investors in Zarminali Health by funding rounds participated
InvestorHQRoundsRoleFirst check
General CatalystUnited StatesSan Francisco, CA2LeadNov 2024
K2 HealthVenturesUnited StatesBoston, MA1ParticipantJan 2026

This data is available for Pro users. Sign up to see all 4 Zarminali Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Zarminali Health

Zarminali Health has acquired 1 company to date.

Last acquisition by Zarminali Health was on June 24th 2025. Zarminali Health acquired Green Tree Pediatrics for undisclosed valuation.


Latest Acquisitions by Zarminali Health

Green Tree Pediatrics
Description
Green Tree Pediatrics is a clinic in Savage, Minnesota, delivering routine check-ups, vaccinations, illness care, and developmental screenings for children from newborns to adolescents.
HQ CountryUnited States
HQ City
Chelsea, MA
Deal Date24 Jun 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Zarminali Health acquisitions and their M&A valuation multiples.

Start Free Trial

Zarminali Health Competitors

Zarminali Health competitors include listed companies like HCA Healthcare, Alcon, Fresenius and Dr. Sulaiman Al Habib, and private ones like IVC Evidensia and Luz Saude.

Public and private companies comparable to Zarminali Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
HCA HealthcareUnited StatesUnited StatesPublicly listed$76B$16B$93B1.9x
AlconSwitzerlandSwitzerlandPublicly listed$10B$2.6B$31B3.3x
FreseniusGermanyGermanyPublicly listed$26B$4.2B$30B1.6x
Dr. Sulaiman Al HabibSaudi ArabiaSaudi ArabiaPublicly listed$3.7B$927M$21B5.9x
IVC EvidensiaUnited KingdomBristolPrivate--$14B-
Luz SaudePortugalLisbonPrivate-$333M$3.2B-

Zarminali Health Public Comps

Zarminali Health is still privately-owned, but its public comps include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, Tenet Healthcare, IHH Healthcare, Rede D'Or São Luiz, Apollo Hospitals, Encompass Health and DaVita.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
HCA Healthcare$76B$16B1.9x1.9x9.4x9.4x
Alcon$10B$2.6B3.4x3.3x13.4x12.5x
Fresenius$26B$4.2B1.6x1.6x10.1x9.4x
Dr. Sulaiman Al Habib$3.7B$927M6.4x5.9x25.2x24.7x
Tenet Healthcare$21B$4.5B1.7x1.6x8.1x7.5x
IHH Healthcare$6.3B$1.5B3.3x3.0x13.8x13.6x
Rede D'Or São Luiz$11B$1.3B1.7x1.6x14.3x8.4x
Apollo Hospitals$2.6B$398M5.3x4.9x34.9x32.1x

This data is available for Pro users. Sign up to see all Zarminali Health competitors and their valuation data.

Start Free Trial

Common questions about Zarminali Health

When was Zarminali Health founded?Zarminali Health was founded in 2024.
Where is Zarminali Health headquartered?Zarminali Health is headquartered in Chicago, IL, United States.
Is Zarminali Health publicly listed?No, Zarminali Health is a private, VC-backed company.
How much funding has Zarminali Health raised?Zarminali Health has raised $150M across 2 funding rounds.
What was Zarminali Health's last funding round?Zarminali Health's last funding round was a $110M Series A in January 2026, led by Healthier Capital.
Who are Zarminali Health's investors?Zarminali Health's investors include General Catalyst, K2 HealthVentures, Healthier Capital and Boston Children's Hospital.
Which companies are comparable to Zarminali Health?Companies comparable to Zarminali Health include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, IVC Evidensia and Luz Saude.
How many companies has Zarminali Health acquired?Zarminali Health has acquired 1 company, including Green Tree Pediatrics.

See companies similar to Zarminali Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial